News

Novo Nordisk said sales of Wegovy more than doubled to 19.87 billion Danish kroner, or $2.76 billion in the fourth quarter, which was just shy of estimates.
Hims & Hers Health Inc.’s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...
Novo Nordisk will replace its chief executive, Lars Fruergaard Jorgensen, the company announced Friday, citing a sharp decline in its stock price that stemmed from increased competition for its ...